UnitedHealth Boosts 2026 Profit Forecast on Tighter Cost Controls, Strong Q2 Beat

UnitedHealth Group on Thursday significantly raised its full-year profit forecast and reported second-quarter earnings that far surpassed analyst expectations, citing tighter control over medical expenses and a strong rebound in its Optum health services unit. The news sent the company's shares up nearly 7% in pre-market trading and lifted the broader health insurance sector.

Upgraded Forecast Follows Q2 Beat

UnitedHealth now anticipates its 2026 adjusted profit will be between $19.50 and $20.00 per share, a substantial increase from its previous forecast of at least $17.75 per share. This revised outlook is well above the analyst consensus of $18.47 per share, according to data compiled by LSEG.

The updated guidance followed a robust second-quarter performance where the company earned an adjusted $6.38 per share, crushing the average analyst estimate of $4.90. Total revenue for the quarter rose to $112 billion from $111.6 billion a year earlier, also beating expectations.

Medical Costs Come Under Control

A key driver of the strong results was improved management of medical spending. The company's medical cost ratio (MCR) — the percentage of premiums used for medical care — came in at 86.70% for the quarter. This was significantly better than both analysts' estimate of 88.47% and the 89.4% ratio reported in the same period last year.

Chief Financial Officer Wayne DeVeydt attributed the improvement to cost controls in its Medicare business, increased payments for Medicaid plans, and changes to insurance plan designs. However, DeVeydt noted these efforts are aimed at "pushing down what is already an elevated number," not a sign of a broader cost trend reversal. The company expects 500,000 members to leave its Obamacare marketplace plans in 2026 due to higher costs following the expiration of government subsidies.

Ad

Optum Unit Rebounds Sharply

The company's Optum health services segment showed a marked turnaround, with operating income increasing 29% year-over-year to $4 billion. This represents a significant recovery from the first quarter, when the unit's operating income fell 15%.

DeVeydt stated that the recovery plan for Optum is "ahead of schedule in year one," with a full return to historical growth levels expected by 2028. He credited the introduction of AI tools with reducing administrative tasks and allowing clinicians more time for patient care, part of a $1.5 billion investment in artificial intelligence under CEO Stephen Hemsley, who returned to lead the company last year.

Market Impact

UnitedHealth's positive results and upgraded forecast provided a boost to the entire health insurance industry. Following the announcement, shares of competitors also rose in premarket trading, including:

• Centene and Humana, which climbed nearly 5% each.
• Elevance and Molina, which gained nearly 3% each.